Leda Mannent

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Claus Bachert, Joseph K. Han, Martin Desrosiers et al. · The Lancet · 2019 · 1.4K citations

Asthma, Nasal Polyps, Allergy +7

Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis

Claus Bachert, Leda Mannent, Robert M. Naclerio et al. · JAMA · 2016 · 769 citations · Full text

Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis

Ikuo Hirano, Evan S. Dellon, Jennifer D. Hamilton et al. · Gastroenterology · 2019 · 434 citations · Full text

Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis

Evan S. Dellon, Marc E. Rothenberg, Margaret H. Collins et al. · New England Journal of Medicine · 2022 · 413 citations

Conjunctivitis in dupilumab clinical trials

Bolanle Akinlade, Emma Guttman‐Yassky, Marjolein de Bruin‐Weller et al. · British Journal of Dermatology · 2019 · 410 citations · Full text